A phase I trial of riluzole and sorafenib in patients with advanced solid tumors and melanoma.

被引：0
|
作者：
Mehnert, Janice M.
Semlani, Neha
Wen, Yvonne
Tan, Antoinette R.
Moss, Rebecca Anne
Adams, Shari
Stein, Mark N.
Ross, Mikel
Kane, Michael P.
Gibbon, Darlene
Wright, John Joseph
Aisner, Joseph
Chen, Suzie
Goydos, James S.
机构：
[1] Canc Inst New Jersey, New Brunswick, NJ USA
[2] UMDNJ, Robert Wood Johnson Med Sch, New Brunswick, NJ USA
[3] Natl Canc Inst, Rockville, MD USA
[4] Rutgers State Univ, Piscataway, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS3112
引用
收藏
页数：1
相关论文
共 50 条
  • [1] CTEP #8850: A phase I trial of riluzole and sorafenib in patients with advanced solid tumors.
    Spencer, Kristen Renee
    Mehnert, Janice M.
    Tan, Antoinette R.
    Moss, Rebecca Anne
    Levinson, Kelly
    Stein, Mark N.
    Huzzy, Lien
    Kane, Michael P.
    Gibbon, Darlene
    Wright, John Joseph
    Aisner, Joseph
    DiPaola, Robert S.
    Chen, Suzie
    Wen, Yvonne
    Goydos, James
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Phase I targeted combination trial of sorafenib and erlotinib in patients with advanced solid tumors
    Duran, Ignacio
    Hotte, Sebastien J.
    Hirte, Holger
    Chen, Eric X.
    MacLean, Martha
    Turner, Sandra
    Duan, Lixia
    Pond, Gregory R.
    Lathia, Chetan
    Walsh, Scott
    Wright, John J.
    Dancey, Janet
    Siu, Lillian L.
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (16) : 4849 - 4857
  • [3] Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors
    Brendel, Erich
    Ludwig, Matthias
    Lathia, Chetan
    Robert, Caroline
    Ropert, Stanislas
    Soria, Jean-Charles
    Armand, Jean-Pierre
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (01) : 53 - 61
  • [4] Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors
    Erich Brendel
    Matthias Ludwig
    Chetan Lathia
    Caroline Robert
    Stanislas Ropert
    Jean-Charles Soria
    Jean-Pierre Armand
    [J]. Cancer Chemotherapy and Pharmacology, 2011, 68 : 53 - 61
  • [5] Phase I trial of sorafenib, bevacizumab, and temsirolimus in advanced solid tumors.
    Westin, Shannon Neville
    Smart, Melody L.
    Pal, Navdeep
    Urbauer, Diana L.
    Janku, Filip
    Wheler, Jennifer J.
    Piha-Paul, Sarina Anne
    Naing, Aung
    Tsimberidou, Apostolia Maria
    Fu, Siqing
    Falchook, Gerald Steven
    Hong, David S.
    Zinner, Ralph
    Subbiah, Vivek
    Culotta, Kirk Salvatore
    Lu, Karen H.
    Coleman, Robert L.
    Kurzrock, Razelle
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] A phase I trial of panobinostat with ipilimumab in advanced melanoma.
    Khushalani, Nikhil I.
    Markowitz, Joseph
    Eroglu, Zeynep
    Giuroiu, Iulia
    Ladanova, Viktoriya
    Reiersen, Pamela
    Rich, Jeani
    Thapa, Ram
    Schell, Michael J.
    Sotomayor, Eduardo M.
    Weber, Jeffrey S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Pharmacokinetic results of a phase I trial of sorafenib (S) in combination with dacarbazine (DTIC) in patients with advanced metastatic melanoma or other solid tumors
    Brendel, E.
    Zafarana, E.
    Figuerola, C.
    Ludwig, M.
    Lathia, C.
    Burk, K.
    Robert, C.
    Soria, J. C.
    Armand, J. P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] A phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with advanced melanoma.
    Shaikh, Saba
    Zang, Yan
    Hanmer, Janel
    Wang, Hong
    Lin, Yan
    Davar, Diwakar
    Zarour, Hassane M.
    Kirkwood, John M.
    Najjar, Yana G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] A Phase I study of sorafenib in combination with capecitabine in patients with advanced, solid tumors
    Awada, A.
    Gil, T.
    Burk, K.
    Vanhamme, J.
    Mancini, I.
    Besse, T.
    Brendel, E.
    Matthys, A.
    Piccart, M.
    Hendlisz, A.
    [J]. EJC SUPPLEMENTS, 2006, 4 (12): : 33 - 34
  • [10] A Phase I Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma
    Sullivan, Ryan J.
    Ibrahim, Nageatte
    Lawrence, Donald P.
    Aldridge, Julie
    Giobbie-Hurder, Anita
    Hodi, F. Stephen
    Flaherty, Keith T.
    Conley, Christine
    Mier, James W.
    Atkins, Michael B.
    McDermott, David F.
    [J]. ONCOLOGIST, 2015, 20 (06): : 617 - 618
12345